Cryogenic OGS

How has been the historical performance of Cryogenic OGS?

Cryogenic OGS has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 22.02 Cr in Mar'23 to 32.90 Cr in Mar'25, and profit after tax rising from 4.08 Cr to 6.09 Cr. The company maintains a healthy balance sheet with no long-term borrowings and improved cash flow.

Answer:<BR>The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On the balance sheet, total assets grew from 23.95 Cr in Mar'23 to 33.73 Cr in Mar'25, with total liabilities also increasing from 23.95 Cr to 33.73 Cr. The company maintained no long-term borrowings, and cash and cash equivalents rose from 8.10 Cr in Mar'23 to 11.07 Cr in Mar'25, indicating a positive cash flow position. Overall, Cryogenic OGS has shown robust growth in sales and profitability, alongside a healthy balance sheet.

Is Cryogenic OGS overvalued or undervalued?

As of October 17, 2025, Cryogenic OGS is considered very expensive and overvalued with a PE ratio of 42.91, despite recent strong stock returns of 17.08% and 22.98% over the past week and month, respectively, making it an unfavorable investment at its current price of 183.00.

As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. <BR><BR>When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00.

Why is Cryogenic OGS Ltd falling/rising?

As of 05-May, Cryogenic OGS Ltd's stock price is declining, currently at 196.95, down 5.54% and underperforming its sector. Despite a positive year-to-date performance of 20.83%, recent trends indicate a significant downward trajectory.

As of 05-May, Cryogenic OGS Ltd's stock price is falling, currently at 196.95, which reflects a decrease of 11.55 or 5.54%. The stock has been underperforming, having lost 21.47% over the last three days, indicating a consecutive decline. Additionally, today's performance shows that it has underperformed its sector by 6.22%. The stock reached an intraday low of Rs 192.05, marking a significant drop of 7.89% during the trading session.<BR><BR>Despite some positive indicators, such as a rise in delivery volume by 5.42% against the 5-day average, the overall trend remains negative. The stock's performance over the past week shows a decline of 6.75%, while it has managed a gain of 16.54% over the past month. However, the year-to-date performance is still positive at 20.83%, contrasting with the Sensex, which has decreased by 9.63% in the same period. The moving averages indicate that while the stock is higher than the 20, 50, 100, and 200-day moving averages, it is lower than the 5-day moving average, suggesting recent weakness. Overall, these factors contribute to the current downward trend in Cryogenic OGS Ltd's stock price.

Which are the latest news on Cryogenic OGS?